FH and renal cell adenocarcinoma: Recent investigations into FH-altered RCC have described a notably low tumor mutation burden, distinctive tumor microenvironments characterized by the infiltration of CD8+ T-cells with PD-L1 expression within tumors, and a profoundly depleted and mutated mitochondrial genome.